Page last updated: 2024-11-01

omeprazole and Digestive System Neoplasms

omeprazole has been researched along with Digestive System Neoplasms in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhao, R1
Lin, S1
Han, M1
Lin, Z1
Yu, M1
Peng, L1

Other Studies

1 other study available for omeprazole and Digestive System Neoplasms

ArticleYear
Does proton pump inhibitors use increase risk of digestive tumors?: A 2-sample Mendelian randomization study.
    Medicine, 2023, Nov-10, Volume: 102, Issue:45

    Topics: Digestive System Neoplasms; Gastrointestinal Neoplasms; Genome-Wide Association Study; Humans; Mende

2023